Category: Colorectal Cancer Prevention
Phani Keerthi Surapaneni
Morehouse School of Medicine
We retrieved electronic medical records from a large safety net hospital between January 2010 and January 2019. We identified average risk patients who received screening for CRC using FIT, colonoscopy or sigmoidoscopy or either. Data regarding screening modalities for CRC were obtained. We utilized ICD-9 and ICD-10 procedure codes for FIT, colonoscopy and sigmoidoscopy. MS excel and STAT software were used for data management and analyses. Two-sided p-value< 0.05 was considered statistically significant.
Results: Our study revealed that over all utilization of FIT was less compared to colonoscopy with 21.5 % vs 70.23% respectively at our institution. Similarly, the percentage of AA patients who received only FIT as a screening from total AA population for CRC was about 20.7% only and colonoscopy was about 70.9%. Table 1.0 summarizes total demographics and percentages of each screening modality. Table 3.0 summarizes trends of CRC screening trends in AA pts.
Multiple screening tests such as colonoscopy, FIT, sigmoidoscopy, Fecal Occult Blood Test (FOBT) and FIT DNA are available to detect CRC. But FIT is most specific (96.4%) compared to other screening modalities. Our study reveals that only 20.7 % of AA patients received FIT as a screening tool for CRC compared to 70.9% who received traditional colonoscopy. More multi center studies are needed to analyze the barriers in utilization of FIT especially amongst AA patients. One potential barrier could be the awareness of FIT as a screening modality for CRC amongst primary care physicians.
Phani Keerthi Surapaneni indicated no relevant financial relationships.
Taiwo Ajose indicated no relevant financial relationships.
Melvin Simien indicated no relevant financial relationships.
Pramod Pantangi indicated no relevant financial relationships.
Manan Shah indicated no relevant financial relationships.